Corpus Intelligence IC Memo — WEATHERFORD REHABILITATION HOSPITAL 2026-04-26 23:28 UTC
IC Memo — WEATHERFORD REHABILITATION HOSPITAL
Investment Committee Memorandum | TX | 26 beds | Grade D | EBITDA uplift $920K
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 673062

WEATHERFORD REHABILITATION HOSPITAL

LOCATIONPARKER, TX·BEDS26·AS OFApril 26, 2026
D
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

WEATHERFORD REHABILITATION HOSPITAL is a 26-bed community hospital in PARKER, TX with $12.5M in net patient revenue and a 25.4% operating margin. The hospital serves a payer mix of 77.4% Medicare, 0.0% Medicaid, and 22.6% commercial.

Thesis: Turnaround. Our ML models identify $920K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 25.4% to 32.8% (+739bps).

Net Revenue HCRIS$12.5M
Current EBITDA COMPUTED$3.2M
Operating Margin COMPUTED25.4%
Occupancy HCRIS76.5%
Revenue / Bed COMPUTED$479K
Net-to-Gross HCRIS72.8%
Distress Probability MLnan%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
257
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 25.4% places it above the state median. Among 257 size-comparable peers (13-52 beds), the median margin is -8.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (13-52), prioritizing same-state peers. 257 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WEATHERFORD REHABILITATION HOS (Target)TX26$12.5M25.4%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
CORYELL MEMORIAL HOSPITALTX25$305.9M-1.5%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
METHODIST HOSPITAL FOR SURGERYTX32$178.4M22.8%
TEXAS SPINE AND JOINT HOSPITALTX20$147.3M30.3%
NORTH CENTRAL SURGICAL HOSPITATX24$143.6M32.0%
SCOTT AND WHITE HOSPITAL TAYLOTX25$139.7M-47.5%
BAYLOR SURGICAL HOSPITAL AT FOTX30$136.0M14.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $920K (739bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$262K+210bp18mo
Cost to Collect4.5%2.5%$249K+200bp12mo
Denial Rate Reduction12.0%6.5%$248K+199bp12mo
A/R Days Reduction5200.0%3800.0%$152K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+8bp6mo

5. EBITDA Bridge

Net Collection Rate
$262K
Cost to Collect
$249K
Denial Rate Reduction
$248K
A/R Days Reduction
$152K
Clean Claim Rate
$10K
Total EBITDA Uplift$920K
Current EBITDA$3.2M
+ RCM Uplift+$920K
Pro Forma EBITDA$4.1M
Current Margin25.4%
Pro Forma Margin32.8%
WC Released (1x)$478K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$4.9M$30.1M6.18x43.9%
Base (11x exit)10.0x11.0x$4.9M$34.7M7.12x48.1%
Bull Case9.0x11.0x$4.4M$39.3M8.96x55.0%
Bull (12x exit)9.0x12.0x$4.4M$44.2M10.07x58.7%
Bear Case11.0x10.0x$5.4M$23.9M4.46x34.9%
Bear (11x exit)11.0x11.0x$5.4M$28.1M5.23x39.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 77.4% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 257 hospitals with 13-52 beds
  • Same-state prioritization (n=258)
  • Comp margins: P25=-36.7% / P50=-8.0% / P75=9.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.